Biotech One joins ETPN, the European Technology Platform on Nanomedicine

Biotech One has joined the European Technology Platform on Nanomedicine (ETPN). The platform connects researchers, biotech companies and industrial partners across Europe.

The company states the problem it wants EncapX® to address: from innovative formulations to industrial-scale manufacturing. The patented supercritical CO₂ nano-encapsulation technology is meant to speed the development and scale-up of liposomes and LNPs for next-generation therapies.

The goals set out with this membership are to build collaborations, to validate new applications, and to bring scalable nano-encapsulation closer to clinical needs. Biotech One says it looks forward to working with the European nanomedicine community.